These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1277391)

  • 1. [Prevention to newborn hyperbilirubinemia through drugs in combination with screening for early prognosis].
    Ivicic L; Palkovicová A; Pramuk V; Reichel F; Rybáková V; Vasil J
    Cesk Pediatr; 1976 May; 31(5):259-61. PubMed ID: 1277391
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of newborn infant hyperbilirubinemia by use of drugs. 8. Recommendation for the use of prevention in combination with a screening test for prognosis].
    Gmyrek D; Bunke H; Cario WR; Daberkow H; Läuter J; Saworra H; Weh L; Syllm-Rapoport I
    Kinderarztl Prax; 1973 Apr; 41(4):174-90. PubMed ID: 4731678
    [No Abstract]   [Full Text] [Related]  

  • 3. An enzyme inductor combination for the prevention of hyperbilirubinemia in premature infants.
    Hinkel GK; Kintzel HW; Schwarze R; Händel A
    Acta Paediatr Scand; 1974 May; 63(3):393-7. PubMed ID: 4838967
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of neonatal hyperbilirubinemia by enzyme inducers. Effectiveness of a phenobarbital-nikethamide association].
    Patriarca PL; Peracino A; Marcovina S; Zecca G
    Minerva Pediatr; 1975 Apr; 27(14):865-73. PubMed ID: 1134450
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of hyperbilirubinemia in premature infants using a combination of two enzyme inductors: phenobarbitol and nikethamide].
    Hinkel GK; Kintzel HW; Schwarze R; Händel A
    Dtsch Gesundheitsw; 1972 Sep; 27(39):1854-7. PubMed ID: 4634399
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood sugar level during the first week of life after administration of phenobarbital and nikethamide (author's transl)].
    Hosková A; Talafant E; Pojerová A
    Cas Lek Cesk; 1976 Feb; 115(7):213-4. PubMed ID: 1260824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neonatal icterus due to hepatic immaturity].
    Chevrel B; Hecht Y
    Presse Med (1893); 1971 Apr; 79(20):929-30. PubMed ID: 4326050
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preventive drug therapy of hyperbilirubinemia in full-term infants].
    Langer P; Berg G; Endig W
    Kinderarztl Prax; 1977 Jan; 45(1):11-4. PubMed ID: 556483
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenobarbital in prophylaxis of neonatal jaundice. A control trial of two regimens.
    Salle B; Pasquer P; Desebbe C; Rouzioux JM; Barouty B
    Helv Paediatr Acta; 1977 Sep; 32(3):221-6. PubMed ID: 372140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine phenobarbital for prevention of neonatal hyperbilirubinemia.
    Thomas CR
    Obstet Gynecol; 1976 Mar; 47(3):304-8. PubMed ID: 1250562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A0 blood-group constellation and preventive use of phenobarbital in neonatal jaundice].
    Czerny M; Hohenauer L
    Klin Padiatr; 1973 Mar; 185(2):133-6. PubMed ID: 4735823
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy in the prevention of transitory hyperbilirubinemia in premature newborn infants].
    Reineke J
    ZFA (Stuttgart); 1976 May; 52(13):681-2. PubMed ID: 1274416
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prenatal prevention of hyperbilirubinemia due to G6PD deficiency].
    Firinu C; Meloni T; Milia S; Virdis P; Lo Dico G; Stoppelli I
    Minerva Ginecol; 1983 May; 35(5):287-90. PubMed ID: 6877650
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].
    Centa A; Camera G; Piccinini A; De Pietro P; Tomatis C
    Minerva Pediatr; 1976 Apr; 28(15):911-21. PubMed ID: 11400
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenobarbital prophylaxis of neonatal hyperbilirubinemia. Evaluation of a nightly dose.
    Thomas CR
    Obstet Gynecol; 1977 Nov; 50(5):607-10. PubMed ID: 909669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on neonatal hyperbilirubinemia of phenobarbital during pregnancy or after birth: practical value of the treatment in a population with high risk of unexplained severe neonatal jaundice.
    Valaes T; Petmezaki S; Doxiadis SA
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):46-54. PubMed ID: 4941650
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of icterus prevention using phenobarbital in 1500 newborn and premature infants].
    Menzel K; Braun W
    Kinderarztl Prax; 1972 Feb; 40(2):62-9. PubMed ID: 4663434
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug prevention of hyperbilirubinemia in newborn infants. 5. Cumulative effect of the combination of the inductors phenobarbital and nikethamide].
    Gmyrek D; Weh L; Kalz M; Bunke H; Cario WR; Lindenau E; Neumann R; Pietsch I; Scigalla P; Sima K; Syllm-Rapoport I
    Dtsch Gesundheitsw; 1972 Nov; 27(47):2221-7. PubMed ID: 4662684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transitory bilirubinemia in the newborn infant. 1. For and against phenobarbital prophylaxis of hyperbilirubinemia in the term infant].
    Menzel K; Buchenau W; Linke M; Thomas A; Töpke B; Wiedemann G
    Padiatr Grenzgeb; 1982; 21(1):1-7. PubMed ID: 7099666
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of toxic hyperbilirubinemia in premature and mature newborn infants by use of an enzyme-inducing combination: phenobarbital-nikethamide].
    Kintzel HW
    Helv Paediatr Acta; 1973; 30():Suppl:35-7. PubMed ID: 4711239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.